首页
数据库
关于我们
联系我们
您当前的位置： 首页 > 数据库
所属年份
2008 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
到
2008 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
检索 清除
手术分类
  • 全部（2447）
  • 腹部手术（342）
  • 胸科手术（70）
  • 血管手术（5）
  • 心脏手术（97）
  • 神经外科（4）
  • 头颈部（35）
  • 骨科（78）
  • 泌尿外科（0）
  • 妇产手术（77）
  • 日间手术（26）
  • 手术室外（28）
  • 创伤和烧伤（0）
  • 非心脏手术（472）
  • 老年（0）
  • 小儿新生儿（189）
  • 特殊患者（42）
  • 未说明手术类型（982）
阶段管理
  • 术前宣教（21）
  • 术前评估（33）
  • 术前用药（15）
  • 术前禁食水（12）
  • 麻醉选择（21）
  • 麻醉用药（10）
  • 术中监测（23）
  • 液体管理（14）
  • 血液保护（3）
  • 体温管理（8）
  • 术后疼痛（62）
  • POD（8）
  • PONV（10）
  • 术后康复（50）
  • 特殊情况（43）
  • 术前肠道准备（9）
排序：
发表时间 阅读量
Array ( [id] => 540 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/540.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:01 [updatetime] => 2024-01-11 15:13:01 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => In all patients scheduled for NCS, an accurate history and clinical examination are recommended.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 所有择期非心脏手术患者应提供准确的病史和临床检查（证据级别：Level C ；推荐强度：Class Ⅰ） [znzldj] => A [_inputtime] => 1704957181 [_updatetime] => 1704957181 [_nrjc] => [_nrsh] => )
推荐意见
所有择期非心脏手术患者应提供准确的病史和临床检查（证据级别：Level C ；推荐强度：Class Ⅰ）

In all patients scheduled for NCS, an accurate history and clinical examination are recommended.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：European Society of Cardiology

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
阅读
Array ( [id] => 512 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/512.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:00 [updatetime] => 2024-01-11 15:13:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => In patients using NOACs, it is recommended that minor bleeding risk procedures are performed at trough levels (typically 12–24 h after last intake). (Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 使用非维生素 K 拮抗剂口服抗凝剂的患者，推荐在低谷水平（通常为最后一次摄入后 12-24 小时）进行出血风险小的手术。（证据级别：Level C ；推荐强度：Class Ⅰ） [znzldj] => A [_inputtime] => 1704957180 [_updatetime] => 1704957180 [_nrjc] => [_nrsh] => )
推荐意见
使用非维生素 K 拮抗剂口服抗凝剂的患者，推荐在低谷水平（通常为最后一次摄入后 12-24 小时）进行出血风险小的手术。（证据级别：Level C ；推荐强度：Class Ⅰ）

In patients using NOACs, it is recommended that minor bleeding risk procedures are performed at trough levels (typically 12–24 h after last intake). (Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：European Society of Cardiology

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
阅读
Array ( [id] => 513 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/513.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:00 [updatetime] => 2024-01-11 15:13:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => In patients with a recent PCI scheduled for NCS, it is recommended that management of antiplatelet therapy is discussed between the surgeon, anaesthesiologist, and cardiologist. (Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 在近期接受经皮冠状动脉介入治疗并计划接受NCS的患者中，推荐外科、麻醉和心内科医生共同讨论抗血小板治疗的管理。（证据级别：Level C ；推荐强度：Class Ⅰ） [znzldj] => A [_inputtime] => 1704957180 [_updatetime] => 1704957180 [_nrjc] => [_nrsh] => )
推荐意见
在近期接受经皮冠状动脉介入治疗并计划接受NCS的患者中，推荐外科、麻醉和心内科医生共同讨论抗血小板治疗的管理。（证据级别：Level C ；推荐强度：Class Ⅰ）

In patients with a recent PCI scheduled for NCS, it is recommended that management of antiplatelet therapy is discussed between the surgeon, anaesthesiologist, and cardiologist. (Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：European Society of Cardiology

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
阅读
Array ( [id] => 506 [catid] => 190 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/506.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:00 [updatetime] => 2024-01-11 15:13:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://academic.oup.com/eurheartj/article/43/39/3826/6675076?login=false [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => Smoking cessation ＞4 weeks before NCS is recommended to reduce post-operative complications and mortality. (Evidence: Level B ，Recommendation: Class 1) [laiyuan] => 推荐NCS术前戒烟>4周，以减少术后并发症和死亡率。（证据级别：Level B ；推荐强度：Class 1） [znzldj] => A [_inputtime] => 1704957180 [_updatetime] => 1704957180 [_nrjc] => [_nrsh] => )
推荐意见
推荐NCS术前戒烟>4周，以减少术后并发症和死亡率。（证据级别：Level B ；推荐强度：Class 1）

Smoking cessation ＞4 weeks before NCS is recommended to reduce post-operative complications and mortality. (Evidence: Level B ，Recommendation: Class 1)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：European Society of Cardiology

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 507 [catid] => 190 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/507.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:00 [updatetime] => 2024-01-11 15:13:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => Control of CV risk factors—including blood pressure, dyslipidaemia, and diabetes—is recommended before NCS. (Evidence: Level B ，Recommendation: Class Ⅰ) [laiyuan] => 推荐NCS术前控制心血管风险因素，包括血压、血脂异常和糖尿病。（证据级别：Level B ；推荐强度：Class Ⅰ） [znzldj] => A [_inputtime] => 1704957180 [_updatetime] => 1704957180 [_nrjc] => [_nrsh] => )
推荐意见
推荐NCS术前控制心血管风险因素，包括血压、血脂异常和糖尿病。（证据级别：Level B ；推荐强度：Class Ⅰ）

Control of CV risk factors—including blood pressure, dyslipidaemia, and diabetes—is recommended before NCS. (Evidence: Level B ，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：European Society of Cardiology

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
阅读
Array ( [id] => 508 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/508.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:00 [updatetime] => 2024-01-11 15:13:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => In minor bleeding risk surgery and other procedures where bleeding can easily be controlled, it is recommended to perform surgery without interruption of OAC therapy. (Evidence: Level B，Recommendation: Class Ⅰ) [laiyuan] => 对于出血风险小的手术和其他操作，因出血容易控制，术前可以不停口服抗凝剂。（证据级别：Level B ；推荐强度：Class Ⅰ） [znzldj] => A [_inputtime] => 1704957180 [_updatetime] => 1704957180 [_nrjc] => [_nrsh] => )
推荐意见
对于出血风险小的手术和其他操作，因出血容易控制，术前可以不停口服抗凝剂。（证据级别：Level B ；推荐强度：Class Ⅰ）

In minor bleeding risk surgery and other procedures where bleeding can easily be controlled, it is recommended to perform surgery without interruption of OAC therapy. (Evidence: Level B，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：European Society of Cardiology

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
阅读
Array ( [id] => 509 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/509.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:00 [updatetime] => 2024-01-11 15:13:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => It is recommended to treat anaemia in advance of NCS in order to reduce the need for RBC transfusion during NCS. (Evidence: Level A，Recommendation: Class Ⅰ) [laiyuan] => 推荐在NCS之前治疗贫血，以减少非心脏手术期间对浓缩红细胞输注的需要。（证据级别：Level A ；推荐强度：Class Ⅰ） [znzldj] => A [_inputtime] => 1704957180 [_updatetime] => 1704957180 [_nrjc] => [_nrsh] => )
推荐意见
推荐在NCS之前治疗贫血，以减少非心脏手术期间对浓缩红细胞输注的需要。（证据级别：Level A ；推荐强度：Class Ⅰ）

It is recommended to treat anaemia in advance of NCS in order to reduce the need for RBC transfusion during NCS. (Evidence: Level A，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：European Society of Cardiology

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
阅读
Array ( [id] => 510 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/510.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:00 [updatetime] => 2024-01-11 15:13:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => The use of an algorithm to diagnose and treat anaemic patients before NCS should be considered. (Evidence: Level C，Recommendation: Class Class Ⅱa) [laiyuan] => 应考虑在NCS之前使用一种算法来诊断和治疗贫血患者。（证据级别：Level C ；推荐强度：Class Ⅱa） [znzldj] => A [_inputtime] => 1704957180 [_updatetime] => 1704957180 [_nrjc] => [_nrsh] => )
推荐意见
应考虑在NCS之前使用一种算法来诊断和治疗贫血患者。（证据级别：Level C ；推荐强度：Class Ⅱa）

The use of an algorithm to diagnose and treat anaemic patients before NCS should be considered. (Evidence: Level C，Recommendation: Class Class Ⅱa)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：European Society of Cardiology

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
阅读
Array ( [id] => 511 [catid] => 191 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/511.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:13:00 [updatetime] => 2024-01-11 15:13:00 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => European Society of Cardiology [pdf] => [tjyjyw] => [lyyw] => In patients with HF undergoing NCS, it is recommended to regularly assess volume status and signs of organ perfusion. (Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 在接受NCS的心力衰竭患者中，推荐常规评估容量状态和器官灌注。（证据级别：Level C ；推荐强度：Class Ⅰ） [znzldj] => A [_inputtime] => 1704957180 [_updatetime] => 1704957180 [_nrjc] => [_nrsh] => )
推荐意见
在接受NCS的心力衰竭患者中，推荐常规评估容量状态和器官灌注。（证据级别：Level C ；推荐强度：Class Ⅰ）

In patients with HF undergoing NCS, it is recommended to regularly assess volume status and signs of organ perfusion. (Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：European Society of Cardiology

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
阅读
Array ( [id] => 483 [catid] => 303 [title] => Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guideline [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => /show/483.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:41 [updatetime] => 2024-01-11 15:12:41 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223056/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2020 [guojia] => ESA/ESICM [pdf] => [tjyjyw] => [lyyw] => In the peri‑operative/periprocedural hypoxaemic patient, we suggest to use NIPPV rather than COT to reduce mortality. (2C) [laiyuan] => 对于围手术期低氧血症患者，我们建议使用无创正压通气（NIPPV）而不是常规氧疗（COT）来降低死亡率。（证据等级：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957161 [_updatetime] => 1704957161 [_nrjc] => [_nrsh] => )
推荐意见
对于围手术期低氧血症患者，我们建议使用无创正压通气（NIPPV）而不是常规氧疗（COT）来降低死亡率。（证据等级：低；推荐强度：弱推荐）

In the peri‑operative/periprocedural hypoxaemic patient, we suggest to use NIPPV rather than COT to reduce mortality. (2C)

证据评价方法：GRADE

指南质量等级：B

年份：2020

国家：ESA/ESICM

来源 Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guideline
原文链接
阅读

地址：甘肃省兰州市七里河区瓜州路418号

邮编：730050

电话：0931-2687109

商务合作热线：0931-2687106

备案号：陇ICP备17005383号-1 联网备案号：62010302000288

技术支持：瑞秀科技